| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |